Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 3/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | ERCC1 | P07992 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
| ▸ | FEN1 | P39748 | 1/20 | 0.30 |
| ▸ | ERCC4 | Q92889 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2810745 | 0.80 | ALOX15 (0.37) | TYMSTDP1ALOX15ALDH1A1 | |
| SCHEMBL2710471 | 0.79 | ALOX15 (0.35) | TYMSTDP1ALOX15ALDH1A1TSHR | |
| SCHEMBL29930656 | 0.79 | ALOX15 (0.35) | TYMSTDP1ALOX15ALDH1A1TSHR | |
| SCHEMBL1713019 | 0.77 | TDP1 (0.39) | TDP1ALOX15ALDH1A1MAPTKDM4E | |
| SCHEMBL29462450 | 0.75 | TYMS (0.50) | TYMSTDP1ALOX15ALDH1A1TSHR | |
| SCHEMBL855450 | 0.75 | TYMS (0.50) | TYMSTDP1ALOX15ALDH1A1TSHR | |
| SCHEMBL2811395 | 0.75 | KMT2A (0.42) | TDP1ALOX15ALDH1A1CYP1A2POLB | |
| SCHEMBL4960390 | 0.73 | TYMS (0.58) | TYMSTDP1ALOX15ALDH1A1TSHR | |
| SCHEMBL261766 | 0.72 | TYMS (0.52) | TYMSTDP1ALOX15ALDH1A1TSHR | |
| SCHEMBL29351267 | 0.72 | TYMS (0.52) | TYMSTDP1ALOX15ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100240908-A1 | ACETYLENE COMPOUND | FUJIFILM CORPORATION (JP) | 2010-09-23 | — | — | US | disclosed |
| CN-101808982-A | Acetylene compound | FUJIFILM CORP | 2010-08-18 | — | — | CN | disclosed |
| EP-2202221-A1 | ACETYLENE COMPOUND | Fujifilm Corporation (JP) | 2010-06-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240908-A1 | ACETYLENE COMPOUND | NAT1, KATNA1, KAT2B | TYMS 4688/4885TDP1 4533/4885ALOX15 1994/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.